Table 1.
Sociodemographic and clinical characteristics of the total sample (N = 148) at each measurement point.
| Baseline | Follow-up | |
|---|---|---|
| Age (mean, SD) | 72.8 (6.7) | 80.9 (6.6)* |
| Females (%, n) | 77.7 (115) | |
| Rural origin (%, n) | 85.1 (126) | |
| Education (years, mean, SD) | 5.12 (2.9) | |
| ≥5 Physical illnesses (%, n) | 9.5 (14) | 31.1 (46) |
| BMI (mean, SD) | 30.5 (4.3) | 30.6 (5.6) |
| Living alone (%, n) | 20.3 (30) | 27.7 (41)* |
| Depression Diagnosis (%, n) | 31.1 (46) | 36.5 (54)* |
| Anxiety Diagnosis (%, n) | 30.4 (45) | 30.4 (45) |
| Psychotropic use (%, n) | 29.7 (44) | 42.9 (63)* |
| Benzodiazepine use (%, n) | 10.1 (15) | 11.5 (17)* |
| Cognitive status (%, n) | ||
| CNI | 46.6 (69) | 26.4 (39)* |
| MCI | 53.4 (79) | 45.9 (68) |
| Dementia | – | 27.7 (41) |
| MCI type (%, n) | ||
| Single-domain | ||
| Amnesic | 26.6 (21) | 20.6 (14) |
| Non amnesic | 16.5 (13) | 27.9 (19) |
| Multi-domain | 57.0 (45) | 51.5 (35) |
*Statistically significant change between baseline and follow-up (paired samples t-test for continuous variables and Chi square test for proportions; p < 0.05).